Urology
Exploratory Randomized Comparison of Mirabegron and Vibegron as First-Line Therapy for Overactive Bladder in Elderly Women.
Hirotaka Sato, Shota Otsuka, Yurie Okumura, Sachiyuki Tsukada, Hiroki Yoshida
Published: 202510.1016/j.urology.2025.11.225
Abstract
OBJECTIVE: To compare mirabegron and vibegron as initial pharmacotherapy for overactive bladder (OAB) in elderly women. METHODS: We conducted a prospective, single-center, randomized, open-label trial including 131 postmenopausal women aged 70 years…
Preview only. Read the full abstract at the source